Bone marrow toxicity in patients with locally advanced cervical cancer undergoing multimodal treatment with VMAT/IMRT: are there dosimetric predictors for toxicity?
The results show that blood levels may correlate with distinct dosimetric subvolumes of critical bone marrow compartments with a potential impact on therapeutic outcome and treatment-related toxicity. The data presented are in line with the previous findings on the relevance of dosimetric exposure of pelvic bony subvolumes.
Authors
- Daniela Hallqvist
- S. E. Combs
- D. Habermehl
- Steffi Pigorsch (ORCID: https://orcid.org/0000-0001-9824-4828)
- Marion B. Kiechle (ORCID: https://orcid.org/0000-0003-4237-2657)
- C. Kormann
Institutions
- Universitätsklinikum Gießen und Marburg (DE)
- TUM Klinikum (DE)
- Helmholtz Zentrum München (DE)
- German Marine Research Consortium (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1186/s40001-024-02041-w
- Citations
- 4
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Technische Universität München